D
Kiniksa Pharmaceuticals International, plc KNSA
$27.74 $0.772.86% NASDAQ
Recommendation
Prev Close
$26.97
Volume
1,095,187
Avg Vol (90D)
623,317
Market Cap
$1.97B
Dividend & Yield
--
52-Week Range
$17.38 - $28.15
P/E (TTM)
--
EPS (TTM)
-$0.2499
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Gap Up Following Earnings Beat
5/1/2025 - MarketBeat
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPS
5/1/2025 - MarketBeat
3 Stocks Including Kiniksa Pharmaceuticals International That May Be Priced Below Intrinsic Value Estimates
5/1/2025 - Simply Wall St
Kiniksa Pharmaceuticals Q1 2025 Earnings: Strong Growth
5/1/2025 - TipRanks Financial Blog
Kiniksa Pharmaceuticals International First Quarter 2025 Earnings: Beats Expectations
4/30/2025 - Simply Wall St
Kiniksa Pharmaceuticals Announces GRAMMY Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
4/30/2025 - Globe Newswire
Kiniksa Pharmaceuticals International (KNSA, $25.88) RSI Indicator left the overbought zone on April 29, 2025
4/30/2025 - Tickeron - Stocks
Kiniksa Pharmaceuticals International (KNSA, $25.88) price may drop as it broke higher Bollinger Band on Apr 29, 2025
4/30/2025 - Tickeron - Stocks
Kiniksa Pharmaceuticals Reports Strong Q1 2025 Growth
4/30/2025 - TipRanks Financial Blog
Decoding Kiniksa Pharmaceuticals International PLC (KNSA): A Strategic SWOT Insight
4/30/2025 - GuruFocus
Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2025 Earnings Call Transcript
4/29/2025 - SeekingAlpha
Video: Tuesday Sector Leaders: Cigarettes & Tobacco, Drugs
4/29/2025 - Market News Video
KNSA Crosses Above Key Moving Average Level
4/29/2025 - Market News Video
Kiniksa Pharmaceuticals Surpasses Q1 2025 Revenue Estimates with $137. ...
4/29/2025 - GuruFocus
Kiniksa Pharmaceuticals, Ltd. (KNSA) Tops Q1 Earnings and Revenue Estimates
4/29/2025 - Zacks Investment Research
Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio ...
4/29/2025 - GuruFocus
Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution
4/29/2025 - GuruFocus
Kiniksa Pharmaceuticals International, plc GAAP EPS of $0.11 beats by $0.09, revenue of $137.7M beats by $5.99M
4/29/2025 - SeekingAlpha.com: All News
Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution
4/29/2025 - Globe Newswire
Jump Financial LLC Sells 31,006 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
4/29/2025 - MarketBeat
Kiniksa Pharmaceuticals International PLC (KNSA) Q1 2025: Everything You Need To Know Ahead Of ...
4/29/2025 - GuruFocus
Kiniksa Pharmaceuticals International PLC (KNSA) Q1 2025 Earnings Report Preview: What To Look For
4/29/2025 - GuruFocus
Examining the Future: Kiniksa Pharmaceuticals's Earnings Outlook
4/28/2025 - Benzinga
Kiniksa Pharmaceuticals International (KNSA, $21.37) price moved above its 50-day Moving Average on April 25, 2025
4/26/2025 - Tickeron - Stocks
Kiniksa Pharmaceuticals International (KNSA, $20.56) Stochastic Oscillator left the overbought zone on April 24, 2025
4/25/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$481.17M
EBITDA (TTM)
-$14.23M
EBIT (TTM)
-$15.80M
Net Income (TTM)
-$16.95M
Balance Sheet
Total Assets (Q)
$599.33M
Total Debt (Q)
$9.92M
Total Liabilities (Q)
$141.84M
Book Value Per Share (Q)
$6.28
Cash Flow
Cash from Operations (TTM)
$44.03M
Cash from Investing (TTM)
-$39.39M
Cash from Financing (TTM)
$11.42M
Net Change in Cash (TTM)
$16.05M
Filings
Filing Date
Tuesday, April 29, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Jul 21 and 25 (est)
Price History
Loading...
Beta
0.96
7-Day Total Return
38.56%
30-Day Total Return
20.19%
60-Day Total Return
48.03%
90-Day Total Return
38.29%
Year to Date Total Return
39.12%
1-Year Total Return
42.99%
2-Year Total Return
152.64%
3-Year Total Return
194.79%
5-Year Total Return
45.54%
52-week Low
Jul 01, 2024 - $17.38
52-week High
Oct 28, 2024 - $28.15
Valuation
Market Cap
$1.97B - Small Cap
Enterprise Value
$1.71B
Price/Sales (TTM)
4.27
Price/Book (Q)
4.29
Dividends and Shares
Shares Outstanding
76.15M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.kiniksa.com
Phone Number
781 431 9100
Address
23 Old Bond Street
London, WIS 4PZ
Country
United Kingdom
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications... more
NASDAQ 05/01/2025 4:00PM Eastern Quotes delayed